KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for AbbVie (ABBV) over the last 7 years, with Q1 2025 value amounting to $4.0 billion.

  • AbbVie's Long-Term Debt Issuances fell 7330.75% to $4.0 billion in Q1 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year decrease of 5994.12%. This contributed to the annual value of $17.0 billion for FY2024, which is N/A changed from last year.
  • As of Q1 2025, AbbVie's Long-Term Debt Issuances stood at $4.0 billion, which was down 7330.75% from $2.0 billion recorded in Q4 2024.
  • Over the past 5 years, AbbVie's Long-Term Debt Issuances peaked at $15.0 billion during Q1 2024, and registered a low of $1.0 billion during Q3 2021.
  • In the last 4 years, AbbVie's Long-Term Debt Issuances had a median value of $2.0 billion in 2022 and averaged $4.8 billion.
  • Data for AbbVie's Long-Term Debt Issuances shows a peak YoY increase of 7330.75% (in 2025) and a maximum YoY decrease of 7330.75% (in 2025) over the last 5 years.
  • Over the past 4 years, AbbVie's Long-Term Debt Issuances (Quarter) stood at $1.0 billion in 2021, then skyrocketed by 100.0% to $2.0 billion in 2022, then changed by 0.0% to $2.0 billion in 2024, then surged by 99.7% to $4.0 billion in 2025.
  • Its Long-Term Debt Issuances was $4.0 billion in Q1 2025, compared to $2.0 billion in Q4 2024 and $15.0 billion in Q1 2024.